Study ID: C18083/2046 | 2010-020768-40

Study Title

Study of Bendamustine Hydrochloride for the Treatment of Pediatric Patients With Relapsed or Refractory Acute Leukemia

Teva Identifier

C18083/2046 | 2010-020768-40

ClinicalTrials.gov Identifier

NCT01088984

Study Status

Completed

Trial Condition(s)

Leukemia

Interventions

Drug: Bendamustine

Study Description

Please refer to ClinicalTrials.gov for a description of the trial
ClinicalTrials.gov study records with inclusion and exclusion criteria
cancer icon for clinical trials

Key Participation Requirements

Gender

Female, Male

Age Range

1 Year to 20 Years

Trial Duration

08/01/2010 - 08/01/2011

Phase

Phase 1/2

Study Type

Interventional